This session discusses the diagnosis and treatment of hypogonadism and testosterone replacement. What we can and cannot give and what the latest data tells us. | 1.0 CE/CME category 1 credits (1.00 Pharmacology) | $30

An update on the current landscape of Alzheimer's diagnosis and treatment, characterized by rapid advances in biomarker-driven diagnosis, the emergence of anti-amyloid and anti-tau therapies, and ongoing challenges in translating clinical trial results into real-world practice, including an update on the integration of novel imaging and plasma biomarkers, and the evolving therapeutic pipeline with monoclonal antibodies and other disease-modifying strategies. | 1.0 CE/CME category 1 credits (1.0 Pharmacology) | $30

Get up to speed on the latest guidelines for preparticipation physicals in youth athletes. This session covers updated screening recommendations, common clearance dilemmas, and practical tips to streamline sports physicals in busy APP practices. | 1.0 CE/CME category 1 credits (0 Pharmacology) | $27.5

This session will focus on pharmacologic strategies to retard progression of chronic kidney disease (RAS blockade, GLP-1 analogues, SGLT-2 inhibitors, and non-steroidal mineralocorticoid antagonists) as well as treatment of chronic kidney disease complications such as hyperkalemia, chronic kidney disease associated pruritus, and anemia. Since cardiovascular disease is the leading cause of death in patients with chronic kidney disease, this session will also focus on the interplay between chronic kidney disease and cardiovascular disease and pharmacologic and non-pharmacologic interventions to reduce the risk of adverse cardiovascular events in this patient population. | 1.5 CE/CME category 1 credits (1.00 Pharmacology) | $35

Uncomplicated and complicated UTI’s are commonly encountered in primary care and emergency settings. Using a case study approach, this session will focus on the management of a UTI’s in the following: the older individual, the person with an indwelling catheter or a structural abnormality, and those with pyelonephritis. In addition, a discussion regarding antimicrobial resistance and its impact on treating the complicated and uncomplicated UTI will be offered. | 1.5 CE/CME category 1 credits (1.50 Pharmacology) | $45

“I am so dizzy” is a common complaint encountered by primary care clinicians every day, and one of the biggest challenges in ensuring that we know what the patient is talking about! The most common differential diagnoses of “dizziness” have very different etiologies, ranging from inner ear, spinocerebellar, neurologic, cardiogenic and volume issues. Because most effective treatments require an accurate diagnosis, careful evaluation of these differentials is critical to best patient outcomes. This session presents a clear approach to differentiating among etiologies as a foundation for best management. | 1.5 CE/CME category 1 credits (0.50 Pharmacology) | $40

Join us for this exciting 2-part unique podcast experience with Dr. Peter Buch MD. In part 1 Dr. Buch reviews the incidence, diagnosis, and differential considerations in inflammatory bowel disease. This episode, in part due to a generous educational grant from Genentech, has 0.5 CE credit. | 0.50 credits | Free

In part-2 of this Friends of NPACE podcast, gastroenterology expert Dr. Peter Buch MD educates on treatments for inflammatory bowel disease including different medication classes and benefits and risks of each. This episode is worth 0.5 CE with 0.5 of pharmacology credit. | 0.50 credits (0.50 Pharmacology) | Free

This educational session provided an in-depth overview of common functional bowel disorders, with a focus on Irritable Bowel Syndrome (IBS), Chronic Constipation, and Gastroesophageal Reflux Disease (GERD). The session aimed to enhance clinical understanding of these conditions through discussion of their pathophysiology, diagnostic criteria, and evidence-based management strategies. | 1.5 CE/CME category 1 credits (1.5 Pharmacology) | $45

This session will provide a fast-paced overview of how to manage patients with Heart Failure with Reduced Ejection Fraction (HFrEF) who are on multiple new medications in a primary care setting. We will explore the guidelines for the appropriate management and treatment (GDMT), how to titrate medications effectively, address the challenges of polypharmacy, and ensure quality care for cardiac patients amid the ever-changing landscape of medical acronyms and standards of care. | 1.0 CE/CME category 1 credits (1.0 Pharmacology) | $30